Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Net Income (2021 - 2025)

Historic Net Income for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $79.4 million.

  • Krystal Biotech's Net Income rose 19212.34% to $79.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.9 million, marking a year-over-year increase of 27988.2%. This contributed to the annual value of $89.2 million for FY2024, which is 71557.81% up from last year.
  • According to the latest figures from Q3 2025, Krystal Biotech's Net Income is $79.4 million, which was up 19212.34% from $38.3 million recorded in Q2 2025.
  • Krystal Biotech's Net Income's 5-year high stood at $80.7 million during Q3 2023, with a 5-year trough of -$50.0 million in Q1 2022.
  • In the last 5 years, Krystal Biotech's Net Income had a median value of -$15.6 million in 2021 and averaged $2.3 million.
  • Per our database at Business Quant, Krystal Biotech's Net Income crashed by 21599.42% in 2022 and then surged by 373015.02% in 2025.
  • Krystal Biotech's Net Income (Quarter) stood at -$21.8 million in 2021, then crashed by 46.99% to -$32.1 million in 2022, then skyrocketed by 127.12% to $8.7 million in 2023, then surged by 423.62% to $45.5 million in 2024, then soared by 74.38% to $79.4 million in 2025.
  • Its Net Income stands at $79.4 million for Q3 2025, versus $38.3 million for Q2 2025 and $35.7 million for Q1 2025.